COSTA MESA, Calif.--(BUSINESS WIRE)--Synthetic Blood International, Inc. (OTCBB:SYBD) today announced that Oxycyte™, its proprietary perfluorocarbon (PFC) therapeutic oxygen carrier and blood substitute, was featured in the November 2006 issue of Popular Science Magazine. The article “Better Than Blood?” highlights Oxycyte’s potential benefits and safety profile, and discusses Oxycyte’s traumatic brain injury clinical trial and its potential use to treat stroke, heart attacks, sickle cell anemia and spinal cord injuries. An electronic copy of this article will be available after October 30, 2006 on the Investor Relations section of the Company’s Web site at www.sybd.com.
